Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma
Yasuhito Arai, Tatsuhiro Shibata(National Cancer Research Institute)
Cited by 554
Related Papers
Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder Cancer
|Gastroenterology|2008|471
Mutant IDH1 Confers an in Vivo Growth in a Melanoma Cell Line with BRAF Mutation
|American Journal Of Pathology|2011|130
Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
|British Journal of Cancer|2011|127
Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma
|British Journal of Cancer|2009|95
Integrated genetic and epigenetic analysis of myxofibrosarcoma
|Nature Communications|2018|85